Table 3.
HCHO | PCHO | LCHF | |
---|---|---|---|
BASELINE | |||
NEAPF1 (mEq·day−1) | 75 ± 19 | 84 ± 18 | 104 ± 35 |
NEAPF2 (mEq·day−1) | 49 ± 9 | 62 ± 16 | 61 ± 15 |
NEAPR (mEq·day−1) | 62 ± 19 * | 63 ± 14 * | 68 ± 31 * |
POST-INTERVENTION | |||
NEAPF1 (mEq·day−1) | 65 ± 12 | 71 ± 16 | 98 ± 15 |
NEAPF2 (mEq·day−1) | 45 ± 4 | 48 ± 4 | 70 ± 7 |
NEAPR (mEq·day−1) | 40 ± 10 * | 58 ± 35 * | 69 ± 17 * |
* significantly different to NEAPF1 (p < 0.05).